Condition
Advanced Solid Tumours clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Advanced Solid Tumours clinical trials that are recruiting, at sites in 8 countries (most in China (3), Australia (2), United Kingdom (2)). By phase: Phase 1 (4), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest Advanced Solid Tumours clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Understanding how genetic mutations affect cancer treatment response in advanced solid tumours | — | Sutton and 1 other locations | Recruiting | Jul 30, 2026 |
| Testing SIM0610 for adults with advanced solid tumors | Phase 1 | Chongqing, Chongqing Municipality and 6 other locations | Recruiting | Jan 16, 2026 |
| Evaluating a new treatment for advanced solid tumors | Phase 1 | Harbin, Heilongjiang | Recruiting | Apr 15, 2025 |
| LM-168 alone or combined with toripalimab for advanced solid tumors | Phase 1/2 | Ryde, New South Wales and 5 other locations | Recruiting | Mar 10, 2025 |
| Evaluating RC220 with Doxorubicin for Advanced Solid Tumours | Phase 1 | Gosford, New South Wales and 8 other locations | Recruiting | Feb 7, 2025 |
| Testing UCB4594 for advanced cancer treatment | Phase 1/2 | London and 3 other locations | Recruiting | Apr 24, 2024 |
| Testing EBC-129 for advanced solid tumors | Phase 1 | Aurora, Colorado and 4 other locations | Recruiting | Jan 27, 2023 |
All recruiting trials (7)
-
Understanding how genetic mutations affect cancer treatment response in advanced solid tumours
This study tests whether mutations found in tumor and blood samples can help predict who will benefit from early-phase cancer treatments.
-
Testing SIM0610 for adults with advanced solid tumors
This will test whether SIM0610 is safe and can shrink tumors in adults with locally advanced or metastatic solid cancers such as non-small cell lung, colorectal, liver, and head and neck cancers.
-
Evaluating a new treatment for advanced solid tumors
This study is testing a new treatment called BA1301 to see if it is safe and effective for adults with advanced solid tumors that haven't improved with other treatments.
-
LM-168 alone or combined with toripalimab for advanced solid tumors
This trial tests whether LM-168, given alone or together with the immunotherapy toripalimab, can shrink tumors or control disease in adults with advanced solid tumors.
-
Evaluating RC220 with Doxorubicin for Advanced Solid Tumours
This study is testing a new treatment called RC220, both alone and with doxorubicin, to see if it is safe and works for adults with advanced solid tumors.
-
Testing UCB4594 for advanced cancer treatment
This study is testing a new drug called UCB4594 to see if it can help treat advanced cancer by targeting a specific protein on cancer cells.
-
Testing EBC-129 for advanced solid tumors
This study is testing a new treatment called EBC-129, alone and with another drug, to see how safe it is and if it can help people with advanced solid tumors.
Related topics
Quick answers
How many Advanced Solid Tumours clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in China (3 trials), Australia (2 trials), United Kingdom (2 trials), Hong Kong (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.